Results 41 to 50 of about 44,864 (270)

Neuroendocrine tumours of the female genital tract: a case-based imaging review with pathological correlation [PDF]

open access: yes, 2015
Background Both primary and secondary gynaecological neuroendocrine (NE) tumours are uncommon, and the literature is scarce concerning their imaging features.
Callé, Catarina   +4 more
core   +1 more source

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues [PDF]

open access: yes, 2015
In a randomized, double-blind, Phase III study, we compared pasireotide long-acting release (pasireotide LAR) with octreotide long-acting repeatable (octreotide LAR) in managing carcinoid symptoms refractory to first-generation somatostatin analogues ...
Eriksson, B.   +18 more
core   +3 more sources

Bronchial Carcinoid Tumour as a Rare Cause of Cushing’s Syndrome in Children: A Case Report and Review of Literature

open access: yesJCRPE, 2020
Cushing’s syndrome (CS) is rare in childhood and adolescence. The most common paediatric cause of CS is exogenous administration of glucocorticoids; either topical, inhaled or oral corticosteroids.
Rahul Saxena   +6 more
doaj   +1 more source

The enigma of struma ovarii [PDF]

open access: yes, 2007
Since its first description in the early part of the twentieth century, struma ovarii has elicited considerable interest because of its many unique features; however, at present a number of aspects remain enigmatic.
Roth, Lawrence M., Talerman, Aleksander
core   +2 more sources

Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours [PDF]

open access: yes, 2016
Overview on primary outcomes and HRQoL results of studies included in systematic review.
Barbara Sperner-Unterweger   +6 more
core   +2 more sources

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay   +5 more
wiley   +1 more source

Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR

open access: yesCase Reports in Oncological Medicine, 2017
We present a case of metastatic recurrence of carcinoid tumor accompanied by carcinoid syndrome in a 68-year-old Japanese man, 12 years after resection of typical pulmonary carcinoid.
Asako Yanagisawa   +10 more
doaj   +1 more source

Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour

open access: yesActa Médica Portuguesa, 2017
The carcinoid syndrome is rare but it is associated with carcinoid heart disease in more than a half of the cases. Carcinoid heart disease is typically characterised by morphological and functional modifications of right-sided valves.
Joana Simões-Pereira   +3 more
doaj   +1 more source

Hedinger Syndrome with Intraoperative Carcinoid Crisis — Understanding the Pathophysiology for a Successful Management

open access: yesBrazilian Journal of Cardiovascular Surgery, 2021
Carcinoid tumors can be a cause for right heart valve disease, also known as Hedinger syndrome or carcinoid heart disease. Proper understanding of the pathophysiology is of the uttermost importance for adequate treatment of these patients, especially ...
Albert Franz Guerrero-Becerra   +4 more
doaj   +1 more source

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial [PDF]

open access: yes, 2018
Telotristat ethyl, a tryptophan hydroxylase inhibitor, was efficacious and well tolerated in the phase 3 TELESTAR study in patients with carcinoid syndrome (CS) experiencing ≥4 bowel movements per day (BMs/day) while on somatostatin analogs (SSAs ...
Anthony, Lowell B.   +17 more
core   +2 more sources

Home - About - Disclaimer - Privacy